2025-05-02 10:07:11
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Tatva Chintan Pharma Chem Ltd posts consolidated Q3FY22 PAT of Rs. 22.80 crore
Posted On : 2022-01-17 22:09:02( TIMEZONE : IST )
Tatva Chintan Pharma Chem Ltd has reported Consolidated financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 109.394 crores during the period ended December 31, 2021 as compared to Rs. 126.419 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 22.807 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 32.412 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 10.29 for the period ended December 31, 2021 as compared to Rs. 15.02 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 109.394 crs | ₹126.419 crs |  -13.47% |
| Net Profit | ₹22.807 crs | ₹32.412 crs | -29.63% |
| EPS | ₹10.29 | ₹15.02 | -31.49% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 109.394 crores during the period ended December 31, 2021 as compared to Rs.80.772 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.22.807 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.20.875 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.10.29 for the period ended December 31, 2021 as compared to Rs.10.39 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 109.394 crs | ₹80.772 crs |  35.44% |
| Net Profit | ₹22.807 crs | ₹20.875 crs | 9.26% |
| EPS | ₹10.29 | ₹10.39 | -0.96% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.344.410 crores during the 9 Months period ended December 31, 2021 as compared to Rs.195.034 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.78.364 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.31.143 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.36.82 for the 9 Months period ended December 31, 2021 as compared to Rs.15.50 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹344.410 crs | ₹195.034 crs | 76.59% |
| Net Profit | ₹78.364 crs | ₹31.143 crs | 151.63% |
| EPS | ₹36.82 | ₹15.50 | 137.55% |
Shares of Tatva Chintan Pharma Chem Ltd was last trading in BSE at Rs. 2868.00 as compared to the previous close of Rs. 2815.70. The total number of shares traded during the day was 17463 in over 3786 trades.
The stock hit an intraday high of Rs. 2957.70 and intraday low of 2803.95. The net turnover during the day was Rs. 50420548.00.
